切换至 "中华医学电子期刊资源库"

中华肩肘外科电子杂志 ›› 2018, Vol. 06 ›› Issue (01) : 54 -58. doi: 10.3877/cma.j.issn.2095-5790.2018.01.009

所属专题: 文献

论著

肩肘外科手术后并发上消化道出血的临床分析
张媛媛1, 刘心怡1, 张黎明1, 吴芸1, 刘玉兰1,()   
  1. 1. 100044 北京大学人民医院消化科
  • 收稿日期:2017-07-16 出版日期:2018-02-05
  • 通信作者: 刘玉兰

Clinical analysis of postoperative upper gastrointestinal bleeding (UGIB) after shoulder and elbow surgery

Yuanyuan Zhang1, Xinyi Liu1, Liming Zhang1, Yun Wu1, Yulan Liu1,()   

  1. 1. Department of Gastroenterology, Peking University People's Hospital, Beijing 100044, China
  • Received:2017-07-16 Published:2018-02-05
  • Corresponding author: Yulan Liu
  • About author:
    Corresponding author: Liu Yulan, Email:
引用本文:

张媛媛, 刘心怡, 张黎明, 吴芸, 刘玉兰. 肩肘外科手术后并发上消化道出血的临床分析[J/OL]. 中华肩肘外科电子杂志, 2018, 06(01): 54-58.

Yuanyuan Zhang, Xinyi Liu, Liming Zhang, Yun Wu, Yulan Liu. Clinical analysis of postoperative upper gastrointestinal bleeding (UGIB) after shoulder and elbow surgery[J/OL]. Chinese Journal of Shoulder and Elbow(Electronic Edition), 2018, 06(01): 54-58.

目的

分析肩肘外科手术后并发上消化道出血的临床特点,并分析其危险因素。

方法

回顾性分析2007年1月至2015年12月于北京大学人民医院行肩肘外科手术治疗后并发上消化道出血患者的临床资料,总结其临床特点,分析引起上消化道出血的危险因素。

结果

肩肘外科术后发生上消化道出血共33例,发生率为3.36%(33/983);单因素分析显示高龄、性别、手术时间长、吸烟史、饮酒史、消化性溃疡或出血史、应用抗凝药物或抗血小板药物等因素与肩肘外科手术患者术后发生上消化道出血明显相关(P <0.05);非条件多因素Logistic分析结果显示高龄、性别、手术时间长、消化性溃疡或出血史、应用抗凝药物或抗血小板药物是肩肘外科手术患者术后发生上消化道出血的独立危险因素(P <0.05)。

结论

肩肘外科手术患者术后发生上消化道出血较为少见,高龄、性别、手术时间长、消化性溃疡或出血史、应用抗凝药物或抗血小板药物是肩肘外科手术患者术后发生上消化道出血的独立危险因素。

Background

Upper gastrointestinal bleeding (UGIB) is one of the serious complications after major orthopedic operation, which is mainly caused by stress-related ulcer (SU) . While showing no symptom in mild cases, UGIB can affect the rehabilitation and life of patients in critical cases. The symptoms of UGIB are usually hard to be detected during the early postoperative stage, which brings some difficulties to the diagnosis and treatment. Usually, more cases of UGIB are reported after major orthopedic surgery. Shoulder and elbow surgery is in rapid development recently, and most of them are small and medium surgeries including internal fixation of peripheral shoulder and elbow fractures, ligament injuries of peripheral shoulder and elbow, repair and reconstruction of rotator cuff injury, shoulder and elbow arthroplasties, etc. Thus, the postoperative UGIB is seldomly reported in these cases. Clinically, the application of prophylactic drug on every patient with shoulder and elbow surgery in avoiding digestive tract bleeding will cause unnecessary medical waste. This study retrospectively analyzed the clinical data of shoulder and elbow surgery in our hospital for nearly 8 years and collected the high-risk factors of postoperative UGIB to better grasp the clinical data of UGIB after shoulder and elbow surgery, prevent postoperative UGIB, and optimize the guideline of clinical individualized treatment.

Methods

(1) Research object. From January 1, 2007 to December 12, 2015, the information of patients with shoulder and elbow surgery under the department of orthopedics and traumatology was collected, and the patients with UGIB were included in this study. Inclusive and exclusive criteria: within one week after operation, the patients had situations including hematemesis, melena and positive occult test. The bleeding of mouth, nasopharynx and biliary tract as well as preoperative active peptic ulcer and gastrointestinal bleeding should be excluded. (2) Research methods. The general and clinical data of patients were statistically analyzed. The general data includes demographic characteristics and lifestyle habits such as age, gender, smoking, drinking, etc. The clinical data includes causes of shoulder and elbow surgery, operation time, operation method, anesthesia, gastrointestinal clinical manifestations, UGIB diagnosis, clinical outcomes, laboratory results, history of peptic ulcer and hemorrhage, anticoagulant or antiplatelet drug history, etc. The risk factors for UGIB were analyzed by single-factor analysis and multiple-factor analysis. (3) Statistical analysis. SPSS 19.0 software was used for statistical analysis. The enumeration data was analyzed by Chi-square test, and the multiple-factor analysis was performed by Logistic regression analysis. A P value < 0.05 was regarded as statistically significant.

Results

(1) General information and clinical data. A total of 33 patients developed UGIB after shoulder and elbow surgery, including 17 males (51.56%) and 16 females (48.44%) . The incidence rate was 3.36% (33/983) , and the average age was (67.609±13.948) years old. The operations that involved UGIB included shoulder and elbow arthroplasty, shoulder and elbow internal fixation, ligament repair and reconstruction, and open reduction and internal fixation of humeral shaft fracture. The average operation time was (131.00±93.36) mins. Gastrointestinal symptoms include hematemesis or vomiting coffee ground vomitus, melena or dark red colored bloody stool, abdominal pain or discomfort, nausea, etc. All the patients included in this study had positive fecal occult blood. A total of 27 cases (81.82%) underwent gastroscopy: 25 cases of gastric mucosal erosion and ulcer were diagnosed as SU (8 cases of which had active bleeding) ; 1 case had esophageal and gastric varices bleeding (the patient suffered from hepatitis B virus-related cirrhosis) ; 1 case had anastomotic ulcer after subtotal gastrectomy. Among the patients who received gastroscopy, 8 out of 23 patients who underwent rapid urease test for detection of Helicobacter pylori were positive. Based on clinical manifestations and the endoscopic diagnosis of upper gastrointestinal bleeding, there were 31 cases of SU, 1 case of esophageal and gastric varices bleeding, and 1 case of anastomotic ulcer after subtotal gastrectomy. All patients with UGIB were treated with proton pump inhibitors (PPI) , and 11 cases were treated with blood transfusion. 31 patients were discharged, and 2 patients died. One case died of UGIB, and the other died of respiratory failure caused by severe pulmonary infection. (2) Single-factor analysis of UGIB after shoulder and elbow surgery. Single-factor analysis was conducted on gender, age, international normalized ratio (INR) , platelet count, operation time, operation method, anesthesia, drinking history, smoking history, peptic ulcer or gastrointestinal bleeding history, anticoagulant or antiplatelet drug application, etc. The results showed that the risk factors of UGIB after shoulder and elbow surgery included male, advanced age, long time operation, smoking history, drinking history, peptic ulcer or gastrointestinal bleeding history, anticoagulant or antiplatelet drug usage, etc. (P <0.05) . (3) Non-conditional multiple-factor Logistic analysis of UGIB after shoulder and elbow surgery. The factors were taken as independent variable for non-conditional multiple-factor Logistic analysis. The results showed that male, advanced age, long operation time, previous history of peptic ulcer or gastrointestinal bleeding and application of anticoagulant or antiplatelet drug were the independent risk factors of UGIB after shoulder and elbow surgery (P <0.05) .

Conclusions

UGIB in patients with shoulder and elbow surgery is relatively uncommon. Advanced age, male, long operation time, history of peptic ulcer or gastrointestinal bleeding, usage of anticoagulant or antiplatelet drug are the independent risk factors of UGIB after shoulder and elbow surgery.

表1 肩肘外科手术后发生UGIB的单因素分析
表2 肩肘外科手术后发生UGIB的非条件性多因素Logistic分析
[1]
Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding[J]. N Engl J Med, 2013, 368(1): 11-21.
[2]
Eastwood GM, Litton E, Bellomo R, et al. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units[J]. Crit Care Resusc, 2014, 16(3): 170-174.
[3]
Bardou MP, Barkun A. Stress-related mucosal disease in the critically ill patient[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(2): 98-107.
[4]
张建伟,王成锋,白晓枫, 等. 胰十二指肠切除术后应激性溃疡出血的危险因素分析[J]. 中华肿瘤杂志,2010,32(1):40-43.
[5]
孙勇,曾学良,廖国庆, 等. 直肠癌患者术后发生应激性溃疡出血的影响因素分析[J]. 中国现代手术学杂志, 2012, 16(5):342-344.
[6]
Reintam Blaser A, Poeze M, Malbrain ML, et al. Gastrointestinal symptoms during the first week of intensive care are associated with poor outcome: a prospective multicentre study[J]. Intensive Care Med, 2013, 39(5): 899-909.
[7]
Madhusudhan TR, Gregg PJ. Gastric protection and gastrointestinal bleeding with aspirin thromboprophylaxis in hip and knee joint replacements[J]. Ann R Coll Surg Engl, 2008, 90(4): 332-335.
[8]
中华医学会外科学分会.应激性黏膜病变预防与治疗——中国普通外科专家共识(2015) [J]. 中国实用外科杂志, 2015, 35(7): 728-730.
[9]
Frandah, W. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit[J]. J Intensive Care Med, 2014, 29(2): 96-103.
[10]
Barletta JF, Kanji S, Maclaren R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada[J]. J Crit Care, 2014, 29(6): 955-960.
[11]
Buendgens L, Bruensing J, Matthes M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea[J]. J Crit Care, 2014, 29(4): e11-e15.
[12]
Freedberg DE, Abrams JA. Does confounding explain the association between PPIs and clostridium difficile related diarrhea?[J]. Am J Gastroenterol, 2013, 108(2): 278-279.
[13]
Lin XH, Young SH, Luo JC,et al. Risk factors for upper gastrointestinal bleeding in patients taking selective COX-2 inhibitors: a nationwide population-based cohort study[J]. Pain Med, 2017. [Epub ahead of print]
[14]
Maclaren R, Campbell J. Cost-Effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients[J]. Crit Care Med, 2014, 42(4): 809-815.
[15]
Barletta JF, Sclar DA. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic Consequences[J]. Pharmacoeconomics, 2014, 32(1): 5-13.
[16]
Lu Y, Loffroy R, Lau J, et al. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding[J]. Br J Surge, 2014, 101(1): E34-E50.
[17]
Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter --the new normal[J]. N Engl J Med, 2014, 371(15): 1459-1461.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[9] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[10] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[11] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[12] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[13] 马东扬, 李斌, 陆安清, 王光华, 雷文章, 宋应寒. Gilbert 与单层补片腹膜前疝修补术疗效的随机对照研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 629-633.
[14] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[15] 宋俊锋, 张珍珍. 单侧初发性腹股沟斜疝老年患者经腹腹膜前疝修补术中残余疝囊腹直肌下缘固定效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 670-674.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?